Skip to content

AUA 2019: A Media Roundup

In This Article

  • Health care professionals at this year’s AUA conference discussed research findings, novel treatment approaches and advances in clinical care
  • These presentations and conversations covered the full spectrum of urologic care, ranging from bladder to prostate, women's health, urologic oncology and beyond
  • Mass General urologists were featured in a range of trade publications on topics such as the disambiguation of the term "vaginal rejuvenation," the release of the first uncomplicated recurrent UTI guideline, transurethral ultrasound ablation and insights on the utility and danger of transvaginal mesh

At the 2019 American Urological Association (AUA) annual conference, specialists from the Massachusetts General Hospital Department of Urology presented on leading research and innovative treatment approaches. Their sessions covered the full spectrum of urologic care, including bladder, prostate, urologic oncology, women's health and more.

Their discussions were covered in various trade articles and videos, which are highlighted below.

Using Transvaginal Mesh for Pelvic Organ Prolapse

Urologist Elise De, MD, spoke with Medscape about the rare utility—and dangers—of transvaginal mesh, the sale of which was banned by the U.S. Food and Drug Administration last April.

OAB Device Has Positive Applications for Improved Patient Compliance

In Urology Times, Ajay Singla, MD, specialist in urinary incontinence and voiding dysfunction in both men and women, shared his thoughts about the results of a recent study of a promising new treatment device for patients with refractory overactive bladder syndrome with urgency urinary incontinence. According to Dr. Singla, these results point toward the device's efficacy with regard to patient compliance with weekly visits for treatment.

Transurethral Ultrasound Ablation Seem Promising; More Information Is Needed

Douglas Middleton Dahl, MD, chief of the Division of Urologic Oncology, spoke with MedPage Today about the early results of transurethral ultrasound ablation.

First-ever Guideline for Diagnosing and Treating Uncomplicated Recurrent UTIs is Practice Affirming

At this year's conference, the AUA released the first-ever guideline for diagnosing and treating uncomplicated recurrent UTI. Ajay Singla, MD, told Medscape that the guideline is a very useful tool that affirms current practice.

Laser Vaginal Procedures Are a Gimmick

In an article published in Medscape, Ajay Singla, MD, spoke against the use of vaginal laser procedures, which are not approved by the FDA.

Learn more about the Department of Urology

Refer a patient to the Department of Urology

Related topics


Orthotopic neobladder reconstruction is becoming the diversion procedure of choice for female cystectomy patients due to recent advances in care for female urology patients.


Rapidly emerging molecular biomarkers will allow oncologists to choose more confidently between radical cystectomy and trimodality therapy for patients with muscle-invasive bladder cancer, as well as identify which patients undergoing trimodality therapy are likely to benefit from adding immunotherapy.